Previous 10 | Next 10 |
2023-09-09 08:15:00 ET With shares of the gene sequencing giant Illumina (NASDAQ: ILMN) collapsing by 53% over the last three years due to a combination of a botched acquisition attempt and weakness in its core business, shareholders are doubtlessly wondering whether the stock's dec...
2023-09-08 00:03:09 ET Summary The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. ...
2023-09-07 11:24:58 ET More on Illumina Seeking Alpha’s Quant Rating on Illumina Historical earnings data for Illumina Financial information for Illumina Illumina: Genetic Plot Twist, Time To Unravel The Stock Illumina, Inc. ( NASDAQ: ILMN ...
2023-09-05 08:07:45 ET More on Illumina Illumina added to Evercore’s Tactical Outperform list on a potential CEO hire Seeking Alpha’s Quant Rating on Illumina Historical earnings data for Illumina Financial information for Illumina Illum...
Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer PR Newswire SAN DIEGO , Sept. 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board o...
2023-09-05 05:53:41 ET Summary Carl Icahn's 13F portfolio value decreased from $22.03B to $15.48B this quarter. The number of holdings in Icahn's portfolio decreased from 17 to 15. The largest five positions in Icahn's portfolio account for approximately 88% of the entire hold...
2023-09-04 21:41:59 ET Summary Illumina specializes in genetic analysis tools; faces legal challenges over GRAIL acquisition and has revised annual guidance. Q2 2023 shows financial recovery, but GRAIL-related legal issues and reduced guidance suggest short to mid-term volatility....
2023-09-04 12:00:00 ET More on AI Cathie Wood's 'Big Ideas 2023' sees Artificial Intelligence as the future Artificial intelligence is a '1995 moment' for tech. That could push stocks even higher Apple CEO Tim Cook says artificial intelligence 'is a major focus of ou...
2023-09-01 09:06:06 ET More on Illumina Illumina, Inc. ( ILMN ) UBS MedTech, Tools and Genomics Summit 2023 Conference (Transcript) Illumina, Inc. 2023 Q2 - Results - Earnings Call Presentation Illumina, Inc.: Collapsing Margins, Rising Debt, Legal Setbacks, And ...
2023-08-21 09:23:00 ET Wall Street analysts are upbeat on California-based biotech Illumina (NASDAQ: ILMN) these days, estimating on average that the stock could climb by up to 27% over the next year. But without some serious and unexpected new developments, that composite estimate ...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO , July 18, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24 , the company will present a Strategy Update on Tuesday, August 13, 2024 starting at ...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...